Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Antibody Formation"" wg kryterium: Temat


Tytuł :
Application of the Antibody-Inducing Activity of Glycosphingolipids to Human Diseases.
Autorzy :
Okuda T; Bioproduction Research Institute, National Institute of Advanced Industrial Science and Technology (AIST) Central 6, 1-1-1 Higashi, Tsukuba 305-8566, Japan.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Apr 06; Vol. 22 (7). Date of Electronic Publication: 2021 Apr 06.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antibody Formation*/drug effects
Antibody Formation*/immunology
Cell Movement*/drug effects
Cell Movement*/immunology
Signal Transduction*/immunology
Antibodies/*immunology
Glycosphingolipids/*pharmacology
Immunoglobulin Class Switching/*drug effects
Animals ; Cytokines/immunology ; Glycosphingolipids/chemistry ; Glycosphingolipids/immunology ; Humans
Czasopismo naukowe
Tytuł :
Coronavirus-specific antibody production in middle-aged mice requires phospholipase A2G2D.
Autorzy :
Zheng J; Department of Microbiology and Immunology and.
Meyerholz D; Pathology, University of Iowa, Iowa City, Iowa, USA.
Wong LR; Department of Microbiology and Immunology and.
Gelb M; Departments of Chemistry and Biochemistry, University of Washington, Seattle, Washington, USA.
Murakami M; Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Perlman S; Department of Microbiology and Immunology and.
Pokaż więcej
Źródło :
The Journal of clinical investigation [J Clin Invest] 2021 Jun 01; Vol. 131 (11).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Antibody Formation*
Antibodies, Viral/*immunology
COVID-19/*immunology
Group II Phospholipases A2/*immunology
Middle East Respiratory Syndrome Coronavirus/*immunology
SARS Virus/*immunology
SARS-CoV-2/*immunology
Severe Acute Respiratory Syndrome/*immunology
Animals ; COVID-19/enzymology ; COVID-19/genetics ; Chlorocebus aethiops ; Group II Phospholipases A2/deficiency ; Mice ; Mice, Knockout ; Severe Acute Respiratory Syndrome/enzymology ; Severe Acute Respiratory Syndrome/genetics ; Vero Cells
Czasopismo naukowe
Tytuł :
Immunogenicity of the BNT162b2 vaccine in frail or disabled nursing home residents: COVID-A study.
Autorzy :
Salmerón Ríos S; Residencia de Mayores San Vicente de Paúl, Diputación de Albacete, Albacete, Spain.
Mas Romero M; Department of Geriatrics, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
Cortés Zamora EB; Department of Geriatrics, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
Tabernero Sahuquillo MT; Department of Geriatrics, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
Romero Rizos L; Department of Geriatrics, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.; CIBERFES, Ministerio de Economía y Competitividad, Spain.; Facultad de Medicina, Universidad de Castilla-La Mancha, Albacete, Spain.
Sánchez-Jurado PM; Department of Geriatrics, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.; CIBERFES, Ministerio de Economía y Competitividad, Spain.; Facultad de Medicina, Universidad de Castilla-La Mancha, Albacete, Spain.
Sánchez-Nievas G; Department of Rheumatology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
Señalada JJB; Department of Microbiology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
García Nogueras I; Residencia de Mayores San Vicente de Paúl, Diputación de Albacete, Albacete, Spain.
Estrella Cazalla JD; Department of Geriatrics, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.; CIBERFES, Ministerio de Economía y Competitividad, Spain.; Diputación de Albacete, Vasco Núñez de Balboa Facility, Albacete, Spain.
Andrés-Pretel F; Department of Statistics, Foundation of the National Paraplegics Hospital of Toledo, Toledo, Spain.
Murillo Romero A; Long-Term Care Facilities Coordination, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
Lauschke VM; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Stebbing J; Department of Surgery and Cancer, Imperial College, Hammersmith Hospital, ICTEM building, London, United Kingdom.
Abizanda P; Department of Geriatrics, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.; CIBERFES, Ministerio de Economía y Competitividad, Spain.; Facultad de Medicina, Universidad de Castilla-La Mancha, Albacete, Spain.
Pokaż więcej
Źródło :
Journal of the American Geriatrics Society [J Am Geriatr Soc] 2021 Jun; Vol. 69 (6), pp. 1441-1447. Date of Electronic Publication: 2021 Apr 02.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibody Formation*
Disabled Persons*
Frail Elderly*
COVID-19/*prevention & control
COVID-19 Vaccines/*immunology
COVID-19 Vaccines/*therapeutic use
Activities of Daily Living ; Aged ; Aged, 80 and over ; COVID-19 Serological Testing ; Comorbidity ; Female ; Health Status Indicators ; Humans ; Longitudinal Studies ; Male ; Nursing Homes ; SARS-CoV-2 ; Spain
Czasopismo naukowe
Tytuł :
Antibody response in patients admitted to the hospital with suspected SARS-CoV-2 infection: results from a multicenter study across Spain.
Autorzy :
Fuentes A; Hospital Universitario Clínico San Cecilio, Instituto de Investigación Ibs, Av, Innovación S/N, 18016, Granada, Spain.
Serrano-Conde E; Hospital Universitario Clínico San Cecilio, Instituto de Investigación Ibs, Av, Innovación S/N, 18016, Granada, Spain.
Roldán C; Complejo Hospitalario de Jaén, Jaén, Spain.
Benito-Ruesca R; Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
Mejías G; Hospital Universitario de Burgos, Burgos, Spain.
Sampedro A; Hospital Universitario Virgen de las Nieves, Granada, Spain.
March-Roselló G; Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
Fernández-Natal I; Complejo Asistencial Universitario de León, León, Spain.
Esperalba J; Hospital Universitario Valle de Hebrón, Barcelona, Spain.
Rodríguez MJ; Hospital Ramón y Cajal, Madrid, Spain.
Martínez de Aguirre P; Clínica Universidad de Navarra, Pamplona, Spain.
Salas C; Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Roc ML; Hospital Universitario Miguel Servet, Zaragoza, Spain.
Soria LM; Hospital San Pedro, Logroño, Spain.
Parra-Grande M; Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
Montero MD; Hospital Universitario La Paz, Madrid, Spain.
Fernández-Roblas R; Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
Franco-Álvarez de Luna F; Hospital Universitario Juan Ramón Jiménez, Huelva, Spain.
Lozano C; Hospital Universitario Virgen del Rocío, Sevilla, Spain.
García F; Hospital Universitario Clínico San Cecilio, Instituto de Investigación Ibs, Av, Innovación S/N, 18016, Granada, Spain. .
Pokaż więcej
Źródło :
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [Eur J Clin Microbiol Infect Dis] 2021 Jun; Vol. 40 (6), pp. 1343-1349. Date of Electronic Publication: 2021 Jan 29.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Antibody Formation*
Antibodies, Viral/*blood
COVID-19/*immunology
Adolescent ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; COVID-19 Serological Testing ; Coronavirus Nucleocapsid Proteins/immunology ; Enzyme-Linked Immunosorbent Assay ; Female ; Hospitalization ; Humans ; Immunoglobulin A ; Immunoglobulin G ; Immunoglobulin M ; Male ; Middle Aged ; Phosphoproteins/immunology ; Sensitivity and Specificity ; Sex Factors ; Spain ; Spike Glycoprotein, Coronavirus/immunology ; Young Adult
Czasopismo naukowe
Tytuł :
Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19.
Autorzy :
Kutsuna S; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: .
Asai Y; AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.
Matsunaga A; Department of Intractable Diseases, National Center for Global Health and Medicine, Tokyo, Japan.
Kinoshita N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Terada M; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Miyazato Y; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Nakamoto T; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Suzuki T; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Saito S; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: .
Endo M; AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.
Kanda K; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Kenji M; Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute, Tokyo, Japan.
Takasaki J; Department of Respiratory Diseases, National Center for Global Health and Medicine, Tokyo, Japan.
Hojo M; Department of Respiratory Diseases, National Center for Global Health and Medicine, Tokyo, Japan.
Ishizaka Y; Department of Intractable Diseases, National Center for Global Health and Medicine, Tokyo, Japan; Vice Director-General, National Center for Global Health and Medicine Research Institute, Tokyo, Japan.
Ohmagari N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Jun; Vol. 27 (6), pp. 808-813. Date of Electronic Publication: 2021 Jan 18.
Typ publikacji :
Journal Article
MeSH Terms :
Antibody Formation*
Antibodies, Viral/*immunology
COVID-19/*immunology
Adult ; Aged ; Angiotensin Receptor Antagonists ; Angiotensin-Converting Enzyme Inhibitors ; Female ; Humans ; Immunoglobulin G/immunology ; Male ; Middle Aged ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus/immunology
Czasopismo naukowe
Tytuł :
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19).
Autorzy :
Anderson EM; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Diorio C; Immune Dysregulation Frontier Program, Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Pediatrics, Division of Oncology, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Goodwin EC; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
McNerney KO; Immune Dysregulation Frontier Program, Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Pediatrics, Division of Oncology, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Weirick ME; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Gouma S; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Bolton MJ; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Arevalo CP; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Chase J; Immune Dysregulation Frontier Program, Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Pediatrics, Division of Rheumatology, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Hicks P; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Manzoni TB; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Baxter AE; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Andrea KP; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Burudpakdee C; Immune Dysregulation Frontier Program, Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Lee JH; Immune Dysregulation Frontier Program, Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Vella LA; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Pediatrics, Division of Infectious Diseases, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Henrickson SE; Department of Pediatrics, Division of Allergy and Immunology, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Harris RM; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Wherry EJ; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Bates P; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Penn Center for Research on Coronavirus and Other Emerging Pathogens, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Bassiri H; Immune Dysregulation Frontier Program, Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Pediatrics, Division of Infectious Diseases, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Behrens EM; Immune Dysregulation Frontier Program, Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Pediatrics, Division of Rheumatology, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Teachey DT; Immune Dysregulation Frontier Program, Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Pediatrics, Division of Oncology, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Hensley SE; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Pokaż więcej
Źródło :
Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2021 May 28; Vol. 10 (5), pp. 669-673.
Typ publikacji :
Journal Article
MeSH Terms :
Antibody Formation*
Antibodies, Viral/*immunology
COVID-19/*immunology
Spike Glycoprotein, Coronavirus/*immunology
Systemic Inflammatory Response Syndrome/*immunology
COVID-19 Serological Testing ; Child ; Female ; Humans ; Immunoglobulin A/immunology ; Immunoglobulin G/immunology ; Immunoglobulin M/immunology ; Male ; SARS-CoV-2 ; Severity of Illness Index
SCR Disease Name :
pediatric multisystem inflammatory disease, COVID-19 related
Czasopismo naukowe
Tytuł :
Clinical features and antibody response of patients from a COVID-19 treatment hospital in Wuhan, China.
Autorzy :
Chen Y; Wuhan Huoshenshan Hospital, Wuhan, China.; Chinese PLA Center for Disease Control and Prevention, Beijing, China.
Ke Y; Wuhan Huoshenshan Hospital, Wuhan, China.; Chinese PLA Center for Disease Control and Prevention, Beijing, China.
Liu X; Wuhan Huoshenshan Hospital, Wuhan, China.; Chinese PLA Center for Disease Control and Prevention, Beijing, China.
Wang Z; Wuhan Huoshenshan Hospital, Wuhan, China.; Department of Clinical laboratory, The 907th Hospital of Joint Logistic Armed Force, Nanping, China.
Jia R; Wuhan Huoshenshan Hospital, Wuhan, China.; Chinese PLA Center for Disease Control and Prevention, Beijing, China.
Liu W; Wuhan Huoshenshan Hospital, Wuhan, China.; Chinese PLA Center for Disease Control and Prevention, Beijing, China.
Yang C; Wuhan Huoshenshan Hospital, Wuhan, China.; Chinese PLA Center for Disease Control and Prevention, Beijing, China.
Jia L; Wuhan Huoshenshan Hospital, Wuhan, China.; Chinese PLA Center for Disease Control and Prevention, Beijing, China.
Wang Y; Wuhan Huoshenshan Hospital, Wuhan, China.; Chinese PLA Center for Disease Control and Prevention, Beijing, China.
Han L; Wuhan Huoshenshan Hospital, Wuhan, China.; Chinese PLA Center for Disease Control and Prevention, Beijing, China.
Xia X; Wuhan Huoshenshan Hospital, Wuhan, China.; Research Institute of Laboratory Medicine, Eastern Theater General Hospital, Nanjing, China.
Zhang S; Wuhan Huoshenshan Hospital, Wuhan, China.; Executive office, The Fourth Military Medical University, Xi'an, China.
Wang C; Wuhan Huoshenshan Hospital, Wuhan, China.; Chinese PLA Center for Disease Control and Prevention, Beijing, China.
Pokaż więcej
Źródło :
Journal of medical virology [J Med Virol] 2021 May; Vol. 93 (5), pp. 2782-2789. Date of Electronic Publication: 2021 Mar 01.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibody Formation*
Antibodies, Viral/*immunology
COVID-19/*drug therapy
COVID-19/*immunology
Adolescent ; Adult ; Aged ; COVID-19/physiopathology ; China ; Female ; Hospitalization ; Hospitals ; Humans ; Immunoglobulin G/immunology ; Immunoglobulin M/immunology ; Male ; Middle Aged ; Pandemics ; RNA, Viral ; Retrospective Studies ; Risk Factors ; SARS-CoV-2 ; Virus Shedding ; Young Adult
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
IgG and IgM antibody formation to spike and nucleocapsid proteins in COVID-19 characterized by multiplex immunoblot assays.
Autorzy :
Shah J; IGeneX Inc, 556 Gibraltar Drive, Milpitas, CA, 95035, USA. .; ID-FISH Technology Inc, 556 Gibraltar Drive, Milpitas, CA, 95035, USA. .
Liu S; ID-FISH Technology Inc, 556 Gibraltar Drive, Milpitas, CA, 95035, USA.
Potula HH; ID-FISH Technology Inc, 556 Gibraltar Drive, Milpitas, CA, 95035, USA.
Bhargava P; IGeneX Inc, 556 Gibraltar Drive, Milpitas, CA, 95035, USA.
Cruz I; IGeneX Inc, 556 Gibraltar Drive, Milpitas, CA, 95035, USA.
Force D; Medical Art Center, 950 Route 35, Middletown, NJ, 07748, USA.
Bazerbashi A; Medical Art Center, 950 Route 35, Middletown, NJ, 07748, USA.
Ramasamy R; ID-FISH Technology Inc, 556 Gibraltar Drive, Milpitas, CA, 95035, USA. .
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2021 Apr 07; Vol. 21 (1), pp. 325. Date of Electronic Publication: 2021 Apr 07.
Typ publikacji :
Journal Article
MeSH Terms :
Antibody Formation*
Antibodies, Viral/*blood
COVID-19/*blood
Coronavirus Nucleocapsid Proteins/*immunology
Spike Glycoprotein, Coronavirus/*immunology
Humans ; Immunoblotting ; Immunoglobulin G/blood ; Immunoglobulin M/blood ; Pandemics ; Phosphoproteins/immunology ; Sensitivity and Specificity ; Seroconversion ; Serologic Tests
Czasopismo naukowe
Tytuł :
The role of protein hydrolysates in prolonging viability and enhancing antibody production of CHO cells.
Autorzy :
Obaidi I; Cell Technology Group, National Institute for Bioprocessing, Research and Training (NIBRT), Fosters Avenue, Mount Merrion, Blackrock, Dublin, A94 X099, Ireland.; College of Pharmacy, University of Babylon, Babylon, Iraq.
Mota LM; Cell Technology Group, National Institute for Bioprocessing, Research and Training (NIBRT), Fosters Avenue, Mount Merrion, Blackrock, Dublin, A94 X099, Ireland.; School of Chemical and Bioprocess Engineering, University College Dublin, Dublin, D04 V1W8, Ireland.
Quigley A; Cell Technology Group, National Institute for Bioprocessing, Research and Training (NIBRT), Fosters Avenue, Mount Merrion, Blackrock, Dublin, A94 X099, Ireland.
Butler M; Cell Technology Group, National Institute for Bioprocessing, Research and Training (NIBRT), Fosters Avenue, Mount Merrion, Blackrock, Dublin, A94 X099, Ireland. .; School of Chemical and Bioprocess Engineering, University College Dublin, Dublin, D04 V1W8, Ireland. .
Pokaż więcej
Źródło :
Applied microbiology and biotechnology [Appl Microbiol Biotechnol] 2021 Apr; Vol. 105 (8), pp. 3115-3129. Date of Electronic Publication: 2021 Apr 01.
Typ publikacji :
Journal Article
MeSH Terms :
Antibody Formation*
Protein Hydrolysates*
Animals ; CHO Cells ; Cell Culture Techniques ; Cricetinae ; Cricetulus ; Culture Media
Czasopismo naukowe
Tytuł :
Evaluation of Antibody Response in Horses After Vaccination With an Inactivated Getah Virus Vaccine Using an Accelerated Immunization Schedule.
Autorzy :
Bannai H; Equine Research Institute, Japan Racing Association, Shimotsuke, Tochigi, Japan. Electronic address: .
Tominari M; Hidaka Training and Research Center, Japan Racing Association, Urakawa, Hokkaido, Japan.
Kambayashi Y; Equine Research Institute, Japan Racing Association, Shimotsuke, Tochigi, Japan.
Nemoto M; Equine Research Institute, Japan Racing Association, Shimotsuke, Tochigi, Japan.
Tsujimura K; Equine Research Institute, Japan Racing Association, Shimotsuke, Tochigi, Japan.
Ohta M; Equine Research Institute, Japan Racing Association, Shimotsuke, Tochigi, Japan.
Pokaż więcej
Źródło :
Journal of equine veterinary science [J Equine Vet Sci] 2021 Apr; Vol. 99, pp. 103396. Date of Electronic Publication: 2021 Feb 03.
Typ publikacji :
Journal Article
MeSH Terms :
Alphavirus*
Antibody Formation*
Animals ; Horses ; Immunization Schedule ; Vaccination/veterinary ; Vaccines, Inactivated
Czasopismo naukowe
Tytuł :
Effects of Banafine , a fermented green banana-derived acidic glycoconjugate, on influenza vaccine antibody titer in elderly patients receiving gastrostomy tube feeding.
Autorzy :
Horie K; Pharma Foods International Co., Ltd., Kyoto, Japan.
Hossain MS; Pharma Foods International Co., Ltd., Kyoto, Japan.
Kim Y; Pharma Foods International Co., Ltd., Kyoto, Japan.
Akiko I; Pharma Foods International Co., Ltd., Kyoto, Japan.
Kon R; Pharma Foods International Co., Ltd., Kyoto, Japan.
Yamatsu A; Pharma Foods International Co., Ltd., Kyoto, Japan.
Kishima M; Wakakusa-Tatsuma Rehabilitation Hospital, Daito, Japan.
Nishikimi T; Wakakusa-Tatsuma Rehabilitation Hospital, Daito, Japan.
Kim M; Pharma Foods International Co., Ltd., Kyoto, Japan.
Pokaż więcej
Źródło :
Journal of food science [J Food Sci] 2021 Apr; Vol. 86 (4), pp. 1410-1417. Date of Electronic Publication: 2021 Mar 25.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Antibodies, Viral/*blood
Antibody Formation/*immunology
Enteral Nutrition/*methods
Glycoconjugates/*administration & dosage
Influenza Vaccines/*immunology
Influenza, Human/*prevention & control
Musa/*immunology
Aged ; Aged, 80 and over ; Antibody Formation/drug effects ; Double-Blind Method ; Female ; Fermentation ; Gastrostomy ; Glycoconjugates/immunology ; Hemagglutination Inhibition Tests ; Humans ; Influenza A Virus, H1N1 Subtype/immunology ; Influenza A Virus, H3N2 Subtype/immunology ; Influenza B virus/immunology ; Influenza Vaccines/administration & dosage ; Influenza, Human/immunology ; Male ; Musa/chemistry ; Probiotics/administration & dosage
Czasopismo naukowe
Tytuł :
Type I IFN-dependent antibody response at the basis of sex dimorphism in the outcome of COVID-19.
Autorzy :
Gabriele L; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. Electronic address: .
Fragale A; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Romagnoli G; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Parlato S; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Lapenta C; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Santini SM; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Ozato K; Division of Developmental Biology, National Institute of Child Health and Human Development, Bethesda, MD, USA.
Capone I; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. Electronic address: .
Pokaż więcej
Źródło :
Cytokine & growth factor reviews [Cytokine Growth Factor Rev] 2021 Apr; Vol. 58, pp. 66-74. Date of Electronic Publication: 2020 Oct 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Antibody Formation*
COVID-19/*diagnosis
COVID-19/*immunology
Interferon Type I/*physiology
SARS-CoV-2/*immunology
COVID-19/epidemiology ; Female ; Humans ; Male ; Pandemics ; Prognosis ; Sex Characteristics
Czasopismo naukowe
Tytuł :
Human follicular helper T lymphocytes critical players in antibody responses.
Autorzy :
Alonso GT; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Fomin DS; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Rizzo LV; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Pokaż więcej
Źródło :
Einstein (Sao Paulo, Brazil) [Einstein (Sao Paulo)] 2021 Mar 05; Vol. 19, pp. eRB6077. Date of Electronic Publication: 2021 Mar 05 (Print Publication: 2021).
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antibody Formation*
Germinal Center/*immunology
T-Lymphocytes, Helper-Inducer/*immunology
B-Lymphocytes/immunology ; Humans
Czasopismo naukowe
Tytuł :
Improving Antibody Production in Stably Transfected CHO Cells by CRISPR-Cas9-Mediated Inactivation of Genes Identified in a Large-Scale Screen with Chinese Hamster-Specific siRNAs.
Autorzy :
Lin PC; Bioprocessing Technology Institute, Agency for Science, Technology and Research (A*STAR), 20 Biopolis Way, #04-01 Centros, Singapore, 138668, Singapore.
Liu R; Cell Line Development, MRL, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ, 07033, USA.
Alvin K; Cell Line Development, MRL, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ, 07033, USA.
Wahyu S; Bioprocessing Technology Institute, Agency for Science, Technology and Research (A*STAR), 20 Biopolis Way, #04-01 Centros, Singapore, 138668, Singapore.
Murgolo N; Bioinformatics, MRL, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ, 07033, USA.
Ye J; Cell Line Development, MRL, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ, 07033, USA.
Du Z; Cell Line Development, MRL, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ, 07033, USA.
Song Z; Bioprocessing Technology Institute, Agency for Science, Technology and Research (A*STAR), 20 Biopolis Way, #04-01 Centros, Singapore, 138668, Singapore.
Pokaż więcej
Źródło :
Biotechnology journal [Biotechnol J] 2021 Mar; Vol. 16 (3), pp. e2000267. Date of Electronic Publication: 2020 Nov 09.
Typ publikacji :
Journal Article
MeSH Terms :
Antibody Formation*
CRISPR-Cas Systems*/genetics
Animals ; CHO Cells ; Cricetinae ; Cricetulus ; RNA, Small Interfering/genetics ; Recombinant Proteins/genetics
Czasopismo naukowe
Tytuł :
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19.
Autorzy :
Wheatley AK; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.; Australian Research Council Centre for Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Melbourne, VIC, Australia.
Juno JA; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Wang JJ; Department of Immunology, College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Selva KJ; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Reynaldi A; Kirby Institute, University of New South Wales, Kensington, NSW, Australia.
Tan HX; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Lee WS; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Wragg KM; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Kelly HG; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.; Australian Research Council Centre for Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Melbourne, VIC, Australia.
Esterbauer R; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.; Australian Research Council Centre for Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Melbourne, VIC, Australia.
Davis SK; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Kent HE; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.; Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC, Australia.
Mordant FL; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Schlub TE; Kirby Institute, University of New South Wales, Kensington, NSW, Australia.; Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Gordon DL; Department of Microbiology and Infectious Diseases, Flinders University and SA Pathology, Flinders Medical Centre, Adelaide, SA, Australia.
Khoury DS; Kirby Institute, University of New South Wales, Kensington, NSW, Australia.
Subbarao K; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.; WHO Collaborating Centre for Reference and Research on Influenza, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Cromer D; Kirby Institute, University of New South Wales, Kensington, NSW, Australia.
Gordon TP; Department of Immunology, College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.; Department of Immunology, SA Pathology, Flinders Medical Centre, Adelaide, SA, Australia.
Chung AW; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Davenport MP; Kirby Institute, University of New South Wales, Kensington, NSW, Australia.
Kent SJ; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia. .; Australian Research Council Centre for Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Melbourne, VIC, Australia. .; Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC, Australia. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Feb 19; Vol. 12 (1), pp. 1162. Date of Electronic Publication: 2021 Feb 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibody Formation*
Immunity, Cellular*
Immunologic Memory*
Antibodies, Viral/*immunology
COVID-19/*immunology
Antibodies, Neutralizing/blood ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/blood ; B-Lymphocytes/immunology ; CD4-Positive T-Lymphocytes/immunology ; Humans ; Immunoglobulin G/immunology ; Longitudinal Studies ; Models, Theoretical ; Neutralization Tests ; T-Lymphocytes, Helper-Inducer/immunology
Czasopismo naukowe
Tytuł :
 
Autorzy :
Meylan P; Professeur honoraire Faculté de biologie et de médecine Université de Lausanne, 1015 Lausanne.
Pokaż więcej
Transliterated Title :
Covid 19 : caractéristiques et durée des réponses anticorps et leurs liens à la gravité de la maladie.
Źródło :
Revue medicale suisse [Rev Med Suisse] 2021 Feb 03; Vol. 17 (724), pp. 278.
Typ publikacji :
Wiadomości
MeSH Terms :
Antibody Formation*
Antibodies, Viral/*immunology
COVID-19/*immunology
COVID-19/*pathology
SARS-CoV-2/*immunology
COVID-19/diagnosis ; Humans ; Prognosis ; Time Factors
Periodyk
Tytuł :
T cell and antibody responses to SARS-CoV-2: Experience from a French transplantation and hemodialysis center during the COVID-19 pandemic.
Autorzy :
Candon S; Department of Immunology and Biotherapies, Rouen University Hospital, Rouen, France.; INSERM U1234, University of Rouen Normandy, Rouen, France.
Guerrot D; Department of Nephrology, Transplantation and hemodialysis, Rouen University Hospital, Rouen, France.
Drouot L; INSERM U1234, University of Rouen Normandy, Rouen, France.
Lemoine M; Department of Nephrology, Transplantation and hemodialysis, Rouen University Hospital, Rouen, France.
Lebourg L; Department of Nephrology, Transplantation and hemodialysis, Rouen University Hospital, Rouen, France.
Hanoy M; Department of Nephrology, Transplantation and hemodialysis, Rouen University Hospital, Rouen, France.
Boyer O; Department of Immunology and Biotherapies, Rouen University Hospital, Rouen, France.; INSERM U1234, University of Rouen Normandy, Rouen, France.
Bertrand D; Department of Nephrology, Transplantation and hemodialysis, Rouen University Hospital, Rouen, France.
Pokaż więcej
Źródło :
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2021 Feb; Vol. 21 (2), pp. 854-863. Date of Electronic Publication: 2020 Nov 06.
Typ publikacji :
Journal Article
MeSH Terms :
Antibody Formation*
Immunocompromised Host*
Kidney Transplantation*
Antibodies, Viral/*immunology
COVID-19/*immunology
Postoperative Complications/*immunology
T-Lymphocytes/*immunology
Adult ; Aged ; Antibodies, Viral/metabolism ; Antigens, Viral/immunology ; Biomarkers/metabolism ; COVID-19/diagnosis ; COVID-19/epidemiology ; COVID-19/etiology ; COVID-19 Nucleic Acid Testing ; Case-Control Studies ; Enzyme-Linked Immunospot Assay ; Female ; France/epidemiology ; Humans ; Male ; Middle Aged ; Pandemics ; Postoperative Complications/diagnosis ; Postoperative Complications/epidemiology ; Renal Dialysis ; T-Lymphocytes/metabolism
Czasopismo naukowe
Tytuł :
Factors affecting antibody response to SARS-CoV-2 in patients with severe COVID-19.
Autorzy :
Shang Y; Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Liu T; Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.; Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
Li J; Department of Orthopedics, Zhongnan Hospital of Wuhan University, Wuhan, China.
Wang X; Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.; Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
Zhou F; Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Pokaż więcej
Źródło :
Journal of medical virology [J Med Virol] 2021 Feb; Vol. 93 (2), pp. 612-614. Date of Electronic Publication: 2020 Aug 21.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibody Formation*
Antibodies, Viral/*blood
COVID-19/*immunology
COVID-19/mortality ; COVID-19 Serological Testing ; China/epidemiology ; Humans ; Immunoglobulin G/blood ; Neoplasms ; Risk Factors ; SARS-CoV-2/immunology ; Seroconversion
Raport
Tytuł :
Recurrence of SARS-CoV-2 infection with a more severe case after mild COVID-19, reversion of RT-qPCR for positive and late antibody response: Case report.
Autorzy :
Alonso FOM; Contraprova Diagnósticos, Rio de Janeiro, Brazil.
Sabino BD; Contraprova Diagnósticos, Rio de Janeiro, Brazil.
Guimarães MAAM; Departament of Preventive Medicine, University Hospital Clementino Fraga Filho, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Varella RB; Department of Microbiology and Parasitology, Biomedical Institute, Fluminense Federal University, Rio de Janeiro, Brazil.
Pokaż więcej
Źródło :
Journal of medical virology [J Med Virol] 2021 Feb; Vol. 93 (2), pp. 655-656. Date of Electronic Publication: 2020 Aug 21.
Typ publikacji :
Case Reports; Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibody Formation*
Severity of Illness Index*
COVID-19/*diagnosis
COVID-19/*immunology
Adult ; Brazil ; COVID-19 Nucleic Acid Testing ; COVID-19 Serological Testing ; Humans ; Male ; RNA, Viral/genetics ; Recurrence ; SARS-CoV-2/genetics
Raport
Tytuł :
Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity.
Autorzy :
Lynch KL; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA.
Whitman JD; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA.
Lacanienta NP; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA.
Beckerdite EW; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA.
Kastner SA; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA.
Shy BR; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA.
Goldgof GM; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA.
Levine AG; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA.
Bapat SP; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA.
Stramer SL; Scientific Affairs, American Red Cross, Gaithersberg, Maryland, USA.
Esensten JH; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA.
Hightower AW; Independent consultant, Bangkok, Thailand.
Bern C; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.
Wu AHB; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Jan 27; Vol. 72 (2), pp. 301-308.
Typ publikacji :
Journal Article
MeSH Terms :
Antibody Formation*
COVID-19*
Antibodies, Viral ; Humans ; Immunoglobulin M ; Kinetics ; SARS-CoV-2 ; Seroepidemiologic Studies ; Severity of Illness Index
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies